Phoenix Rising Companies Announces Morpheus Robotics Acquisition Progress and Dental Implant Product Developments
Phoenix Rising Companies Announces Morpheus Robotics Acquisition Progress and Dental Implant Product Developments
PARK CITY, UT / ACCESSWIRE / October 13, 2022 / Phoenix Rising Companies OTCMarkets PINK:PRCX:
犹他州帕克城/ACCESSWIRE/2022 年 10 月 13 日/ 菲尼克斯崛起公司 OTCMarkets PINK: PRCX:
DS Chang, CEO and Chairman of the company is pleased to announce progress towards the previously announced planned acquisition of Morpheus Robotics, Inc. Morpheus was originated and has continuing operations in Italy.
该公司首席执行官兼董事长DS Chang很高兴地宣布，在先前宣布的收购Morpheus Robotics, Inc.的计划方面取得了进展。Morpheus起源于意大利，并在意大利持续运营。
While in the current pre-financing stage DS Chang continues to work with Massimo Strada and Stephen Lee of Morpheus. The Morpheus team has kept DS and Phoenix informed of ongoing advances in Morpheus product development.
在当前的预融资阶段，DS Chang继续与Morpheus的Massimo Strada和Stephen Lee合作。Morpheus 团队已向 DS 和 Phoenix 通报了 Morpheus 产品开发的持续进展。
The product of greatest interest currently is Morpheus' robotic devices for dental implantation. These machines, when finished and deployed, will aid oral surgeons to implant replacement teeth in patients with highly improve accuracy, greatly reducing both complications and pain. Further, use of the Morpheus machinery saves time and money.
目前最受关注的产品是Morpheus的用于植牙的机器人设备。这些机器完成并部署后，将帮助口腔外科医生在患者身上植入替换牙齿，从而大大提高准确性，从而大大减少并发症和疼痛。此外，使用Morpheus机器可以节省时间和金钱。
The Parties are working to complete the Share Exchange Agreement as soon as possible to be followed by the closing between the entities.
双方正在努力尽快完成《股票交换协议》，随后各实体之间将达成协议。
Further developments will be announced.
进一步的事态发展将公布。
ABOUT MORPHEUS: Morpheus Medical Robotic System is the result of an unprecedented combination of Artificial Intelligence Based Software, new generation medical imaging, holographic reality, robotic applications, pervasive sensors natively integrated, delivering a new and unique minimally invasive robotic surgery ecosystem.
关于 MORPHEUS：Morpheus Medical Robot System 是基于人工智能的软件、新一代医学成像、全息现实、机器人应用、原生集成的无处不在的传感器组合的结果，提供了一个全新而独特的微创机器人手术生态系统。
The Morpheus Super-Calculus GPU Based Appliance is a parallel vectorial supercomputing machine able to process 40 trillion operations per second guaranteeing a fluid ultra-high definition 4X4K, ultra-fast artificial intelligence segmentation, real-time Holographic mixed reality modeling, real-time visual guidance self-alignment.
基于 Morpheus Super-Calculus GPU 的设备是一款并行矢量超级计算机器，能够每秒处理 40 万亿次操作，保证流畅的超高清晰度 4X4K、超快的人工智能分割、实时全息混合现实建模、实时视觉引导自校准。
Morpheus started with and continues to use a primary engineering team in Milan, Italy.
Morpheus 最初并继续使用意大利米兰的主要工程团队。
PHOENIX COMMENTS DS Chang, CEO of Phoenix reminds readers of his prior comments, to wit, "This acquisition, if completed, represents a move towards Westernizing Phoenix with new acquisitions that offer a substantial possibility of incredible growth of the company and its stake holders"
PHOENIX 评论菲尼克斯首席执行官 DS Chang 提醒读者想起他之前的评论，换句话说：“此次收购如果完成，代表着通过新的收购向菲尼克斯西方化迈进，这为公司及其股东实现令人难以置信的增长提供了很大的可能性。”
For information on Phoenix Rising Companies, visit .
contact ir@phoenix-cos.com
有关菲尼克斯崛起公司的信息，请访问。
联系 ir@phoenix-cos.com
CAUTIONARY STATEMENT
警示声明
This press release contains forward-looking statements. Known and unknown risks may cause actual future results to vary widely. The statements are based upon Management's and Advisor's current expectations, estimates and projections; are not guarantees of future performance and are subject to certain risks and uncertainties and other factors, some of which are beyond Management's control and are difficult to predict. A reader of this press release should not place undue reliance on forward-looking statements. Investors should understand investing in shares of PRCX involves a high degree of risk and should seek competent investment advice prior to purchasing shares.
本新闻稿包含前瞻性陈述。已知和未知的风险可能导致未来的实际结果差异很大。这些报表基于管理层和顾问当前的预期、估计和预测；不能保证未来的业绩，受某些风险和不确定性以及其他因素的影响，其中一些是管理层无法控制的，难以预测。本新闻稿的读者不应过分依赖前瞻性陈述。投资者应了解投资PRCX的股票涉及高度的风险，并应在购买股票之前寻求有效的投资建议。
SOURCE: Phoenix Rising Companies
来源： 菲尼克斯崛起公司
译文内容由第三方软件翻译。